These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


321 related items for PubMed ID: 16563995

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Perioperative high-dose-rate brachytherapy in locally advanced and recurrent gynecologic cancer: Initial results of a phase II trial.
    Martínez-Monge R, Jurado M, Cambeiro M, Valero J, Villafranca E, Alcázar JL.
    Brachytherapy; 2006; 5(4):203-10. PubMed ID: 17118310
    [Abstract] [Full Text] [Related]

  • 4. Phase I-II trial of perioperative high-dose-rate brachytherapy in oral cavity and oropharyngeal cancer.
    Martínez-Monge R, Gómez-Iturriaga A, Cambeiro M, Garrán C, Montesdeoca N, Aristu JJ, Alcalde J.
    Brachytherapy; 2009; 8(1):26-33. PubMed ID: 19041280
    [Abstract] [Full Text] [Related]

  • 5. Perioperative high-dose-rate brachytherapy in soft tissue sarcomas of the extremity and superficial trunk in adults: initial results of a pilot study.
    Martínez-Monge R, San Julián M, Amillo S, Cambeiro M, Arbea L, Valero J, González-Cao M, Martín-Algarra S.
    Brachytherapy; 2005; 4(4):264-70. PubMed ID: 16344256
    [Abstract] [Full Text] [Related]

  • 6. High-dose-rate interstitial brachytherapy in recurrent and previously irradiated head and neck cancers--preliminary results.
    Narayana A, Cohen GN, Zaider M, Chan K, Lee N, Wong RJ, Boyle J, Shaha A, Kraus D, Shah J, Zelefsky MJ.
    Brachytherapy; 2007; 6(2):157-63. PubMed ID: 17434110
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer.
    Machtay M, Rosenthal DI, Chalian AA, Lustig R, Hershock D, Miller L, Weinstein GS, Weber RS.
    Int J Radiat Oncol Biol Phys; 2004 May 01; 59(1):72-7. PubMed ID: 15093901
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Salvage high-dose-rate (HDR) brachytherapy for recurrent head-and-neck cancer.
    Hepel JT, Syed AM, Puthawala A, Sharma A, Frankel P.
    Int J Radiat Oncol Biol Phys; 2005 Aug 01; 62(5):1444-50. PubMed ID: 16029806
    [Abstract] [Full Text] [Related]

  • 11. High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer.
    Niehoff P, Dietrich J, Ostertag H, Schmid A, Kohr P, Kimmig B, Kovács G.
    Strahlenther Onkol; 2006 Feb 01; 182(2):102-7. PubMed ID: 16447017
    [Abstract] [Full Text] [Related]

  • 12. Re-resection with brachytherapy for locally recurrent soft tissue sarcoma arising in a previously radiated field.
    Pearlstone DB, Janjan NA, Feig BW, Yasko AW, Hunt KK, Pollock RE, Lawyer A, Horton J, Pisters PW.
    Cancer J Sci Am; 1999 Feb 01; 5(1):26-33. PubMed ID: 10188058
    [Abstract] [Full Text] [Related]

  • 13. IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes.
    Sulman EP, Schwartz DL, Le TT, Ang KK, Morrison WH, Rosenthal DI, Ahamad A, Kies M, Glisson B, Weber R, Garden AS.
    Int J Radiat Oncol Biol Phys; 2009 Feb 01; 73(2):399-409. PubMed ID: 18556144
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The role of pulsed-dose-rate brachytherapy in previously irradiated head-and-neck cancer.
    Strnad V, Geiger M, Lotter M, Sauer R.
    Brachytherapy; 2003 Feb 01; 2(3):158-63. PubMed ID: 15062138
    [Abstract] [Full Text] [Related]

  • 16. Intraoperative radiation therapy for recurrent head-and-neck cancer: the UCSF experience.
    Chen AM, Bucci MK, Singer MI, Garcia J, Kaplan MJ, Chan AS, Phillips TL.
    Int J Radiat Oncol Biol Phys; 2007 Jan 01; 67(1):122-9. PubMed ID: 17084543
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Determinants of complications and outcome in high-risk squamous cell head-and-neck cancer treated with perioperative high-dose rate brachytherapy (PHDRB).
    Martínez-Monge R, Pagola Divassón M, Cambeiro M, Gaztañaga M, Moreno M, Arbea L, Montesdeoca N, Alcalde J.
    Int J Radiat Oncol Biol Phys; 2011 Nov 15; 81(4):e245-54. PubMed ID: 21620582
    [Abstract] [Full Text] [Related]

  • 20. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast.
    Trombetta M, Julian TB, Werts DE, McWilliams W, Kim Y, Miften M, Parda D.
    Am J Clin Oncol; 2009 Jun 15; 32(3):314-8. PubMed ID: 19451803
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.